Recently, the website of the Ministry of Finance announced that with the approval of the State Council, the Customs Tariff Commission of the State Council issued an announcement that the import and export tariffs of some commodities will be adjusted in 2023. The announcement shows that from January 1, 2023, my country will implement a provisional import tax rate lower than the most-favored-nation tax rate for 1020 commodities, which refers to the import of robots in countries and regions where the most-favored-nation treatment clause is applicable” target=”_blank”> Surgical robots will achieve zero import tariffs to meet the needs of industrial development and technological progress.
Surgical robot, referred to as RAS, should be strictly called robot-assisted surgery. In order to be more easily understood and accepted by the public, the concept of “surgical robot” was first introduced 30 years ago.
In 2000, the fourth-generation surgical robot Da Vinci Assisted Robot System (Intuitive Surgical Company) was approved by the US FDA and is mainly used in radical resection of prostate cancer in urology and benign tumor resection in gynecology.
Domestic surgical robot companies are in the process of rapid incubation and growth. The surgical robot industry, which is still in its early stages of development, still has high technology, R&D and time costs, and cannot do without the support of policies and capital. Relevant enterprises should seize the opportunity of the national policy to support the industry and strive to solve the problems faced in the current development.
At present, the investment and financing of the domestic surgical robot industry has accelerated significantly. According to statistics, the number of investment and financing has increased significantly, and the total financing amount of the entire track has exceeded 3 billion yuan. From the perspective of the investment community, surgical robots have received high attention from both academic and clinical aspects, and have shown a certain value in health economics. In the next 5-10 years, surgical robots should be more and more recognized by the market.
“The benchmark of the surgical robot industry is the foreign Da Vinci robot. In comparison, there is no domestic manufacturer that can match it. It takes time for technological breakthroughs and market cultivation.” Lu Hanchen, director of Gaogong Robotics Industry Research Institute, told Caijing.com.
He believes that surgical robots need to solve the problem of stability and reliability, which requires the blessing and protection of deep technology, which is the basis for building doctors’ trust; on the other hand, surgical robot companies need to solve the problem of ease of use.
The Northeast Securities Research Report believes that China’s surgical robots are in the stage of shifting from relying on imported surgical robots to technological innovation based on domestic participants, and they are optimistic about the future development potential of domestic surgical robots for a long time.
Due to the unbalanced distribution of medical resources in my country, the phenomenon of cross-regional medical treatment in different places is very obvious. This not only increases the difficulty and cost of medical treatment, but also reduces the technical level of grassroots medical institutions due to unreasonable flow directions, and the medical advantages of large hospitals cannot be obtained. Utilization has virtually wasted medical resources. Especially for common diseases such as fractures, remote diagnosis and remote surgery can make full use of reasonable medical resources to solve the problem of difficult and expensive treatment for patients. In response to this, my country is building a demonstration scenario for the application of 5G remote orthopedic surgery robots to explore an economical, effective and safe remote diagnosis and treatment model for orthopedic surgery robots.
Although medical robots have many technical and conceptual difficulties to be overcome, Qi Peng is generally optimistic about the future of robots. He believes that robots are a continuous concept and will become the product of integrating various technologies, software and hardware. With the country’s emphasis on high-end medical equipment, the core key technology areas will continue to promote the research and development of independent intellectual property rights, and at the same time combine with scientific research in universities to gradually realize industrialization.
Heavy adjustments, the surgical robot market will be a blue ocean in 2023
With the “Tianji” surgical robot, it is equivalent to installing a “see-through eye” and a “third hand” for doctors, which greatly improves the accuracy of surgery and reduces the risk of surgery.” At the same time, as long as the parameters are planned in advance, young Physicians can complete complex screw placement operations in various channels, which greatly reduces the surgical learning curve, truly makes complex operations safer, realizes minimally invasive routine operations, and maximizes the benefits of “intelligence + manual”.
Surgical robots were originally a medical project that provided medical protection for astronauts. Doctors can use the video imaging system, sit next to the machine to operate the system, control the robotic arm, and perform surgery on patients remotely. Surgical robots have become more and more widely used in the medical industry in recent years because of the clearer field of view, more flexible operation of the instrument arm, and no vibration.